London Stock Exchange welcomes Spectral MD Holdings, Ltd. to AIM

London Stock Exchange today welcomes Spectral MD Holdings, Ltd. (“Spectral MD” of the “Company”) (AIM: SMD) a predictive analytics group that develops proprietary AI algorithms and optical technology for faster treatment decisions in wound care, headquartered in Dallas, Texas, U.S.A. 

Using its DeepView® Wound Imaging Solution, an internally developed AI technology and multispectral imaging system which has designated FDA Breakthrough Device status, the Company is able to distinguish between damaged and healthy human tissue invisible to the naked eye, providing 'Day One' healing assessments for burn wounds and diabetic foot ulcers (‘DFU’).

The Company has to date received substantial support from the US government with contracts from institutions such as Biomedical Advanced Research and Development Authority (BARDA), National Science Foundation (NSF), National Institute of Health (NIH) and Defense Health Agency (DHA) in support of the burns application for its DeepView® system.

Spectral MD successfully completed an oversubscribed Placing for gross proceeds of £11.3 million (c.US$16 million). The Company has one principal trading subsidiary, Spectral MD, Inc, and has set up a permanent establishment in the UK from which it will be growing its business in the UK and EU. Spectral MD’s market capitalisation is expected to be approximately £80million on Admission. 

The Directors believe that Admission will be an important step in the Company’s development as it will assist in building the profile of the business, particularly in Europe where it is looking to spearhead growth, which will provide access to wider pools of capital. 

The Company believes that Admission will provide further funding to undertake clinical trials for the DFU application, which is a larger market than burn wound assessment, in the US, UK and EU and to develop a UK-based EMEA headquarters to support CE-Mark approval and commercial expansion.

Wensheng Fan, CEO of Spectral MD Holdings, Ltd., said: “We are delighted with the support shown by investors in our AIM IPO, which is a key milestone in our commercial development. Our technology enables clinicians to make ‘Day One’ decisions on burn injuries which can significantly reduce patient recovery time and improve the outcome of the healing process. These funds will support further development of our DFU application, build a greater UK and European presence and help the Company gain the necessary regulatory approvals to bring the DeepView® technology into these markets. 

“We are now well funded to expand our portfolio and develop our DFU technology through to commercial launch, which positions us well in a significant and continually growing market worldwide. Diabetes affects over 30 million people in the US and more than 415 million globally.

“Spectral MD has the opportunity to support patient recovery from life-changing injuries worldwide and revolutionise the management of wound care. We look forward to keeping our shareholders updated as we deliver on that mission.”

Quick facts

Market: AIM
Instrument market cap (£m)
Listing/Admission to trading
22 Jun 2021
Looking for new and recent issues?

More recent

London Stock Exchange welcomes Kin + Carta to celebrate becoming the first B Corporation on the Main Market

London Stock Exchange welcomes global digital transformation consultancy Kin + Carta for a Market Open ceremony to celebrate it becoming the first company to certify as a B Corp on the London Stock Exchange.

The rigorous, independent B Corp assessment evaluates how a company's operations and business model impacts on employees, communities, the environment, and customers. Certificatio

Learn more
London Stock Exchange welcomes Skillcast Group plc to AIM

The Skillcast Group sets up compliance portals to help companies educate their staff and record, analyse, and evidence staff activities to cope with their regulatory and ESG (environmental, social and governance) obligations. Its technology application provides e-learning management, in-person training management, CPD (continuing professional development), policy attestation, staff declarations

Learn more
London Stock Exchange welcomes Hambro Perks Acquisition Company

London Stock Exchange welcomes Hambro Perks Acquisition Company, a special purpose acquisition vehicle sponsored by Hambro Perks Limited, the international investment firm focused on technology investing, to the Main Market under the ticker symbol HPA1.

Hambro Perks was founded in 2013 with the aim of providing capital and hands-on support to innovative and

Learn more
London Stock Exchange Welcomes Gelion Plc to AIM

London Stock Exchange today welcomes Gelion plc, the global energy storage innovator, on to the AIM market.

Gelion’s mission is to provide global energy storage solutions that are robust, safe and affordable with low environmental impact, enabling clean power and fresh water for all.

The Company aims to positively impact the transition to a net-zero-carbon economy by deployi

Learn more